Routine liver function tests are frequently abnormal in patients with giant cell arteritis and polymyalgia (GCA and PMR). Elevation of alkaline phosphatase is seen in up to 70% of patients with GCA and/or PMR.1 2 Serum albumin is often low,3 4 and there may be modest elevation of transaminases.14 s Abnormal retention of bromsulphalein is common4 6 and a prolonged half life of galactose was noted in one-third of the patients described by Malmvall and Bengtsson.7 The underlying pathological process which produces these changes and its relationship to the pathogenesis of the condition have yet to be adequately explained. Although biochemical and histological studies of the liver have been frequently reported, there are only 10 reports of radionuclide scanning of the liver in GCA.
Accepted for publication 21 We therefore wish to report the results of radionuclide scanning of the liver in six patients with GCA.
Patients and methods
Six patients had radionuclide liver scans carried out during investigation of abnormal liver function tests, before the diagnosis of PMRJGCA was made. These patients were part of a retrospective study of 108 patients with PMR/GCA, of whom 72% had a raised alkaline phosphatase level. Only the six patients discussed here had scans performed. None gave a history of excessive alcohol intake, and other causes of hepatomegaly and abnormal liver function were excluded.
Clinical details. The main features on presentation are shown in Table 1 . Three had a mixed picture of PMR and GCA, and three had GCA only. All six fulfilled our diagnostic criteria for PMR/GCA.8 In the cases we have reported here it is impossible to identify a specific abnormality causing the varying scan findings and biopsy results. Arteritis of the hepatic vessels would be most likely (of all the possibilities suggested) to cause the abnormalities seen.
The clinical implications are important. It is not generally recognised that liver scans may be abnormal in PMR/GCA. In patients presenting with non-specific features the finding of an abnormal radionuclide scan may mislead the physician into suspecting underlying malignancy. Even if PMR/ GCA is suspected, additional pathology may still be sought. Treatment with steroids may be delayed, putting the patient at risk of complications such as blindness.
Liver function tests and liver size returned to normal in all our patients after treatment with steroids. It seems likely that the scans also reverted to normal, but unfortunately follow-up scans were not obtained. A prospective study is planned to investigate further these previously unreported liver scan abnormalities in PMR/GCA.
It is unusual now for a subject as wide as this to be tackled in a lengthy textbook by a single author. Dr Moll has tried to encompass the whole spectrum of management and has succeeded.
Although, inevitably, a large proportion of the book is taken up with a consideration of drugs, a fair appreciation is given to assessment, physical treatment and surgical treatment of the rheumatic diseases. The historical sections in the first chapter and the general principles of treatment in the second are both of lasting interest and value. The sections on drugs are most comprehensive but have already dated-for example, the recent withdrawal of certain anti-inflammatory analgesics-and to remain useful will need regular revision. The author is to be congratulated on his most comprehensive bibliography throughout the book.
I find this a useful reference work but think that it would need frequent revision to remain current. It deserves a place on the shelves of medical libraries especially for non-specialists, junior staff, and students. The problem of regular updating is one which the author and publishers will need to consider.
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